Systemic amyloidoses: What an internist should know.

Link to article at PubMed

Related Articles

Systemic amyloidoses: What an internist should know.

Eur J Intern Med. 2013 Nov 18;

Authors: Palladini G, Merlini G

Systemic amyloidoses are rare, complex diseases caused by misfolding of autologous proteins. Although these diseases are fatal, effective treatments exist that can alter their natural history, provided that they are started before irreversible organ damage has occurred. The cornerstones of the management of systemic amyloidoses are early diagnosis, accurate typing, appropriate risk-adapted therapy, tight follow-up, and effective supportive treatment. Internists play a key role in suspecting the disease, thus allowing early diagnosis, starting the diagnostic workup and selecting patients that should be referred to specialized centers, judiciously titrating supportive measures, and following patients throughout the course of the disease. Here we review the pathogenesis, diagnosis and treatment of the most common forms of systemic amyloidoses.

PMID: 24262289 [PubMed - as supplied by publisher]

Leave a Reply

Your email address will not be published.